Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for relapse prevention in opioid use disorder
2022-001997-70Phase 2Active
- Sponsor
- University of Cyprus
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ketamine in opioid use disorder (OUD), sponsored by University of Cyprus. Started Nov 2022; status: active.
02
Drugs
ketamine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2022-001997-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001997-70.